Pulmonary Vascular
-
Experts to spotlight considerations for mechanical circulatory support devices in cardiothoracic surgery
Karuna Puttur Rajkumar, MD, MBBS, will chair a Monday session on the initial evaluation, troubleshooting, and optimization of mechanical circulatory support in cardiothoracic surgery.
-
Experts to explore imaging modalities for the often-overlooked right heart
Navitha Ramesh, MD, MBBS, FCCP, will chair a session on available imaging techniques and considerations for evaluating the complex structure and function of the right ventricle.
-
Beyond the pump: Clinical and psychosocial dimensions of LVAD therapy
Advanced HFrEF carries high mortality, but LVAD therapy can improve survival, heart function, and quality of life.
-
Shared decision-making in PAH
Shared decision-making is a collaborative process where clinicians and patients make informed health care decisions together, balancing medical evidence with patient values, which is especially important in complex conditions like PAH.
-
Pooled data suggest sotatercept as novel disease-modifying therapy for PAH
Aaron B. Waxman, MD, PhD, FCCP, said he believes the drug will become a first-line therapy option, but questions remain regarding when to initiate treatment.
-
Turning the tide in right ventricular failure: The role of mechanical support
As mechanical circulatory support technologies advance, understanding the unique features of right-sided devices is essential for optimal patient selection.
-
Intersection of American Heart Month and Black History Month offers chance to highlight disparities in care
Marcus St. John, MD, said health system-wide checklists can combat implicit bias and help ensure all patients receive appropriate care.
-
Consequences of wildfire smoke exposure extend beyond local area
In a recent study, Mary E. Maldarelli, MD, and colleagues demonstrated that wildfires can increase health risks even from thousands of miles away.
-
Major takeaways from the seventh world symposium on PH
The core definition of pulmonary hypertension (PH) remains a mean pulmonary arterial pressure (mPAP) > 20 mm Hg, with precapillary PH defined by a pulmonary arterial wedge pressure (PCWP) ≤ […]
-
New developments on the forefront of intermediate-risk pulmonary embolism
Patients with intermediate-risk pulmonary embolism (IRPE), or those with right ventricular dysfunction without overt hemodynamic instability, represent a heterogenous population with short-term mortality ranging from 2% to 17%.1 While systemic […]
-
Right heart catheterization practice patterns in pulmonary hypertension in the US
In the right clinical scenario, three key hemodynamic components obtained by right heart catheterization (RHC) define precapillary pulmonary hypertension (PH) warranting vasodilator treatment: mean pulmonary arterial pressure >20 mm Hg, […]
-
Empowering ICU physicians in MCS critical care
Intensive care physicians around the nation are pivotal in improving shock-related patient outcomes. At present time, there is still a dearth of available dual-boarded cardiology and intensive care physicians around […]
